Serum concentrations of vascular endothelial growth factor in an infant treated with ranibizumab for retinopathy of prematurity
Editor, Vascular endothelial growth factor (VEGF) is considered to be the major growth factor mediating retinal vascularization in retinopathy of prematurity (ROP). Intravitreal anti-VEGF treatment with bevacizumab has been shown to be effective in treating ROP in the BEAT-ROP trial (Mintz-Hittner e...
Saved in:
| Main Authors: | , , , , , , |
|---|---|
| 格式: | Carta |
| 语言: | 英语 |
| 出版: |
2012
|
| 在线阅读: | https://doi.org/10.1111/j.1755-3768.2012.02469.x https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1755-3768.2012.02469.x |
| 标签: |
添加标签
没有标签, 成为第一个标记此记录!
|